November - 2020
| Previous Next | Showing Journal 3 of 4 |
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19J.H Stone, M.J Frigault, N.J Serling-Boyd, et al for the BACC Bay Tocilizumab Trial Investigators New Eng J Med, 2020, 10.1056/NEJMoa2028836 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
November |
Previous Comments
No Comments yet.
Comment
Severe COVID-19 infection is characterised by markedly abnormal inflammatory markers, including IL6, ferritin and CRP. Also, higher serum IL-6 concentrations are associated with higher levels of SARS-CoV-2 viraemia, prolonged viral RNS sheeting, progression to MV and death. This RCT...